HEALIOS K.K. (4593) Other
Market cap
¥42.5B
P/E ratio
Helios develops stem cell treatments for hard-to-treat diseases using both somatic stem cells and iPS cells to create regenerative medicines.
| 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | -5.5 | -3.4 | -3.9 | -5.3 | -5.6 | -6.1 | -5.2 | -6.2 | -11.5 | 1.7 | 12.4 |
| Return on equity (%) | - | - | ||||||||||||
| Employees | 3 | 14 | 37 | 44 | 58 | 74 | 93 | 109 | 114 | 116 | 71 | 64 | 65 | 75 |